이오플로우
1,490KRWMarket close of 10/21 (Wed)
No trade that dayMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)1,490KRWFlat 0.00%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Volume
- 0×10K shares
- 0 KRW
Open, high and low are not shown — the source has no bar for the reference date
Market close of 10/21 (Wed)
Where it sits in the 1-year range
0%0% of the way up from the lowest close in 1 year (252 sessions) · -90.8% from the high
Something to check
1 to check: no trades this day
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto checkNo trades this day (0 shares)
- Trading valuenot verifiedNo trading that day, so not compared with usual trading value
- Recent filingsnot verifiedOutside filing data coverage, so not verified
The other 3
- Foreign & institutionalnot verified
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue97.91 million KRW
- vs. year ago
- -89.9%
- vs. prior quarter
- -42.7%
- Operating income-3.4B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Turned to loss
- Operating margin-3,456.1%
- vs. year ago
- +6,430.2 pp
- vs. prior quarter
- -55,607.6 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-09-30Same sector · 의료·정밀기기
Up +2.11%· 56 of 101 stocks up, preferred shares excluded · trading value 249.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 나노엔텍 | Close over the last 20 sessions +10.6% | Up +8.13% | 39.0B KRW |
| 케이씨텍 | Close over the last 20 sessions +38.5% | Up +9.89% | 31.4B KRW |
| 디아이 | Close over the last 20 sessions +20.2% | Up +5.63% | 24.2B KRW |
| 티에스이 | Close over the last 20 sessions +9.5% | Up +3.42% | 20.1B KRW |
| 레메디 | Close over the last 20 sessions -0.3% | Up +4.50% | 19.6B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.